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Introduction: Patients with symptomatic chronic heart failure (sCHF) and implanted cardiac resyn-
chronization device (CRTD) were included in this retrospective study in order to evaluate possible dif-
ferences in mitral (MR) and tricuspid (TR) valvular regurgitation severity, NYHA class and left ventri-
cle ejection fraction (LVEF) between male and female CRTD patients during follow up of 6 months after 
CRTD implantation. 
Patients and Methods: We included 135 patients (89 men, 46 women) with sCHF due to any cause with 
implanted CRTD according to guidelines with optimal medical therapy regardless of atrial fibrillation 
or in sinus rhythm. Clinical (NYHA class) and echocardiographic data (valve pathology, LVEF) were 
assessed  before and 6 months after CRTD implantation. Using color and continuous wave Doppler, 
PISA, regurgitation volume and vena contracta measurements, mitral regurgitation (MR) and tricuspid 
regurgitation (TR) were stratified in 3 grades. Echocardiography was recorded always by the same 
echo-technician to avoid inter-observer variability.
Results: Mean age of patients was 60 (±10) years. The results showed improvement in LVEF from 25% 
up to 36% (p=0.006) in all patients regardless of sex and age, as well as worsening of TR (p<0.001) and 
no difference in MR (p=0.195). In male patients (N=89), significant worsening in MR and TR was present 
(p<0.05) while there was no significant worsening in MR (p=0.42) nor TR (p=0.06) in female patients 
(N=46). In patients older than 60 years (N=82, female 27 (33%), male 55 (67%)), as well as younger than 
60 years (N=53; female 19 (36%), male 34 (64%)) significant worsening of TR grade was observed (p<0.05), 
while the grade of MR remained the same (p=0.255 and p=0.534). An improvement in NYHA class was 
observed in 75 patients (71%), no change in 25 patients (24%) and worsening in 5 patients (5%). Overall 
improvement in NYHA class was statistically significant (p<0.001).
Conclusion: Six months after CRTD implantation the severity of MR and TR remained the same in 
female patients while significant worsening of MR and TR severity was found in male patients. TR 
worsening might be due to implanted electrodes. The age of patients had no impact on LVEF, TR and 
MR change. Despite improvement in clinical status and NYHA class, the echocardiography results did 
not meet our expectations.1-4 Due to limited number of patients the results were not divided according 
to the etiology of CHF.
